Trailing Twelve Months Revenue Growth: Kintara Pharma (KTRA)

Public company logo of kintara.com (KTRA)

Kintara Therapeutics (KTRA) is developing anti-tumor agents through partnerships with medical centers and strategic M&A. The laboratory search for new formulas is accelerating through the implementation of robotic screening. The current year-over-year sales trend over 12 months demonstrates revenue dynamics, where 0.00 captures the current value of the indicator. A merger with a cell therapy platform helps the company diversify its clinical risks.

Kintara Therapeutics (KTRA): Revenue Growth YoY (Last 12 Months) from 02/11/2024 to 11/18/2026

Kintara Therapeutics - analytical breakdowns and key metrics (KTRA)

- stock price and consensus target price:
- company stock exchange capitalization indicators:
Summary company analytics:Kintara
Brand item of Kintara Pharma

This indicator measures the revenue growth rate over the last four quarters relative to the previous year, neutralizing seasonal fluctuations to identify the net direction of business development. For Kintara Therapeutics (KTRA), which focuses on developing therapies for rare oncological diseases, this metric reflects the commercial efficiency of its scientific activities, as clearly evidenced by the 12-month annual revenue trajectory.

Who Kintara Therapeutics competes with

Incyte Pharma - Sales Growth YoY (Last Twelve Months)|HUTCHMED Corp - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Nuvation Bio Inc.|DAWN: Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Monopar Pharma MNPR|Revenue Growth YoY (Last 12 Months) INBX|Trailing Twelve Months Revenue Growth I-Mab Biopharma IMAB|Revenue Growth YoY (Last 12 Months) FENC (Fennec Pharmaceuticals)|HRTX (Heron Therapeutics Inc) - Revenue Dynamics YoY (Last Twelve Months)|Nuvectis Pharma, Inc. - Revenue Growth YoY (Last 12 Months)|Revenue Change YoY (Last 12 Months) CHRS (Coherus BioSciences)|Corbus Pharma - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) CRDF (cardiffoncology.com)|BYSI: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth BioAtla Corp (BCAB)|Sales Growth YoY (Last Twelve Months) Lixte Biotechnology Holdings, Inc.|CTXR: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) CLRB|Sales Growth YoY (TTM) BioLineRx Corporation (BLRX)|Sales Growth YoY (Last Twelve Months) Can-Fite BioPharma, Ltd. CANF|APRE (aprea.com) - Trailing Twelve Months Sales Growth|KZIA: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Silexion Therapeutics|NuCana plc (NCNA) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) Chimerix, Inc|Revenue Growth YoY (Last 12 Months) CYCC|Revenue Growth YoY (Last 12 Months) G1 Therapeutics (GTHX)|Sales Growth YoY (Last Twelve Months) Kronos Bio Corporation (KRON)|Revenue Growth YoY (Last 12 Months) Oncternal ONCT|Portage Biotech - Revenue Growth YoY (Last 12 Months)